Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Motilitone for Gastric Emptying in Functional Dyspepsia
NCT02151708Unknown
- Sponsor
- Samsung Medical Center
- Start
- Jun 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Motilitone in functional dyspepsia (FD) (3 arms), sponsored by Samsung Medical Center. Primary endpoint: Gastric Emptying Rate. Status: unknown.
02
Drugs
Motilitone
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT02151708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02151708.